In The Media
Behind the knoSYS 100: Building the Genome Supercomputer
The knoSYS® platform k100 model is featured in Bio-IT World as the “Genome Supercomputer.” An excerpt: In a clinical setting, processing and comparing large numbers of genomes is not as important as speed, confidentiality, data protection, and the ability to organize...
2012: The Year When Genomic Medicine Started Paying Off
An excerpt of an interesting article mentioning Knome [emphasis ours]… Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome...
A Bloomberg Terminal For DNA Sequencing
Forbes staff, Matthew Herper, compares the knoSYS to a Bloomberg terminal in an article on October 1, 2012. An excerpt: [The knoSYS] is essentially a realization that sometimes experts want particular types of data a few steps away, putting the DNA analysis...
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes
Luke Timmerman of Xconomy covers Knome’s announcement of a new CEO and signing of la rge deal with Johns Hopkins.Excerpt: Like a lot of biotech executives focused on developing drugs, Martin Tolar has long been skeptical of the value of genomics in bringing...
Knome Participates in MassTLC Life Sciences Roundtable
Knome was recently honored to participate in MassTLC’s Big Data & Life Sciences roundtable. According to the report: MassTLC convened a Big Data Life Sciences roundtable, held on November 7, 2013, which included representatives from pharma, biotech, personalized...
Direct-to-Consumer Genomics Reinvents Itself
An excerpt of an interesting article mentioning Knome [emphasis ours]: Cambridge, Massachusetts–based Knome made one of the splashiest entries into the field, but has now turned entirely to contract research. The company began providing DTC whole-genome...
Ready or Not, Genomics is Coming to a Hospital Near You
Luke Timmerman reports on the leap genomics has taken from academic research and big pharma to patient care in hospitals and clinics and how Knome is responding to this new demand. Excerpt: Like Foundation Medicine, Knome is also seeing demand grow from...
Knome’s New CEO Signals New Directions in Genome Interpretation
Bio IT World’s Kevin Davies covers Knome’s announcement of its new CEO and discussion of 2012 direction. Full article.
Knome’s knoSYS™100 Featured in the New York Times
An excerpt of an interesting article featuring Knome… The price of sequencing a person’s genome — putting in order all three billion base pairs of DNA in a set of human chromosomes — keeps dropping. But interpreting the billions of letters in a person’s DNA...
George Church on The Colbert Report
Watch our co-founder George Church on The Colbert Report promoting his book Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves.
Knome on NOVA (science series on PBS)
On Wednesday, March 28th, Knome appeared on a special episode of NOVA, Cracking Your Genetic Code. In the show, we help describe how the interpretation of human genomes is helping to solve medical mysteries and revolutionize personal healthcare.